Entia Biosciences, Inc.
Entia Biosciences, Inc.
Aktie · US29384E1047 (OTC)
Übersicht
Kein Kurs
Schlusskurs OTC 03.11.2025: 0,0001 USD
03.11.2025 21:00
Aktuelle Kurse von Entia Biosciences, Inc.
BörseTickerWährungLetzter UmsatzKursTagesveränderung
OTC: UTC
UTC
ERGO
USD
03.11.2025 21:00
0,0001 USD
0,00 USD
Firmenprofil zu Entia Biosciences, Inc. Aktie
Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics, and other products. The company's portfolio of formulations include ErgoD2, a pharmaceutical grade organic compound from whole food that contains the micro-nutrients; L-Ergothioneine, a naturally occurring amino acid and master antioxidant; and vitamin D, an antioxidant. In addition, it is also developing products for the chronic kidney disease and other diseases, as well as providing cosmeceuticals and other beauty products under the GROH brand name. Entia Biosciences, Inc. offers its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon.
Erhalte tagesaktuelle Insights vom finAgent über Entia Biosciences, Inc.

Unternehmensdaten

Name Entia Biosciences, Inc.
Firma Entia Biosciences, Inc.
Website https://www.entiabio.com
Heimatbörse OTC UTC
ISIN US29384E1047
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Timothy A. Timmins
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,0 T
Adresse 13565 SW Tualatin-Sherwood Road, 97140 Sherwood
IPO Datum 2008-01-18

Ticker Symbole

Name Symbol
Over The Counter ERGO
Weitere Aktien
Investoren, die Entia Biosciences, Inc. halten, haben auch folgende Aktien im Depot:
CEZ 24/31 MTN
CEZ 24/31 MTN Anleihe
HERTZ HOLDS NL 16/21 REGS
HERTZ HOLDS NL 16/21 REGS Anleihe
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025